Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer [Phase 2]
This update summarizes a completed Phase 2 safety and toxicity study of sorafenib in patients with renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Safety Study of RAD001 to Treat Patients With Metastatic Kidney Cancer [Phase 2]
A Phase 2 safety study evaluating RAD001 (everolimus) in patients with metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney Cancer [Phase 2]
The Phase 2 safety study evaluating a tumor-targeting drug plus an immune therapy for renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Phase I/II Trial of RAD001 Plus Nexavar in Patients With Kidney Cancer [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase I/II study evaluating the combination of RAD001 (everolimus) and Nexavar (soraf…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Study of Pegylated Alfa Interferon, Sunitinib and Tarceva in Patients With Metastatic RCC [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating pegylated alfa interferon, sunitinib, and tarceva in patients with metastatic renal cell carcinoma has…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-15Clinical Trial Update: Contrast Enhanced Intraoperative Ultrasound for Detection and Characterization of Renal Mass Undergoing Open Partial Nephrectomy [NA]
A completed study evaluating contrast-enhanced intraoperative ultrasound for detecting and characterizing renal masses during open partial n…
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Efficacy of Ultrasound Contrast Agent to Assess Renal Masses [Phase 2]
Phase 2 clinical trial evaluating the efficacy of an ultrasound contrast agent for assessing renal masses, including renal cell carcinoma, h…
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: Quantitative Imaging Metrics From CECT in Measuring Disease Response or Progression in Patients With Kidney Cancer
This completed clinical trial investigates quantitative imaging metrics from contrast-enhanced CT (CECT) to measure disease response or prog…
-
CLINICAL_TRIALS withdrawal · 2016-03-03Clinical Trial Update: A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell Cancer [NA]
This clinical trial (NCT02307474) evaluating SBRT with adjuvant pazopanib for renal cell carcinoma has been withdrawn.
-
CLINICAL_TRIALS research · 2016-03-01Clinical Trial Update: A Phase II Trila of Sunitinib Schedule 4/2 vs. Shedule 2/1 as First Line Therapy in Metastatic Renal Cell Carcinoma. [Phase 2]
Phase II trial investigating two Sunitinib dosing schedules as first-line therapy for metastatic renal cell carcinoma; status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Cediranib Maleate in Treating Patients With Recurrent or Metastatic Kidney Cancer That Cannot Be Removed By Surgery [Phase 2]
Phase 2 trial evaluating cediranib in patients with recurrent or metastatic renal cell carcinoma not removable by surgery; study completed a…
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: BEZ235 in Patients With Advanced Renal Cell Carcinoma (RCC) [Phase 1, Phase 2]
A Phase 1/2 clinical trial of BEZ235 (dactolisib) in patients with advanced renal cell carcinoma was terminated, with results posted in Febr…
-
CLINICAL_TRIALS research · 2016-02-25Clinical Trial Update: A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect)
A completed prospective study evaluating acute cardiovascular effects of first-line sunitinib in metastatic renal cell carcinoma, with focus…
-
CLINICAL_TRIALS other · 2016-02-22Clinical Trial Update: DC Vaccine Combined With CIK Cells in Patients With Renal Cell Carcinoma [Phase 1, Phase 2]
This is a clinical trial update on a dendritic cell vaccine combined with cytokine-induced killer cells in renal cell carcinoma (Phase 1 and…
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF [Phase 1, Phase 2]
Phase 1/Phase 2 trial evaluating a dendritic cell tumor fusion vaccine with GM-CSF in renal cell carcinoma; results were posted after comple…
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: Assessing Everolimus in Fist Line Treatment on Patients With Metastatic Kidney Cancer [Phase 2]
Phase II trial evaluating everolimus as first-line therapy for metastatic kidney cancer has been terminated. The update notes the study stat…
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients [Phase 4]
Phase 4 trial evaluating CYP3A4 and CYP1A2 phenotyping to tailor Sunitinib or Erlotinib therapy in cancer patients, including non-small cell…
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: A Phase 2 Study of ASONEP™ to Treat Unresectable and Refractory Renal Cell Carcinoma [Phase 2]
A Phase 2 trial evaluating ASONEP for unresectable and refractory renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-01-18Clinical Trial Update: PF-04856884 (CVX-060) In Combination With Axitinib In Patients With Previously Treated Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 trial of PF-04856884 (CVX-060) plus axitinib in previously treated metastatic renal cell carcinoma has been terminated; results post…
-
CLINICAL_TRIALS trial_result · 2016-01-13Clinical Trial Update: A Norwegian Observational Trial Evaluating the Treatment of Advanced Renal Cell Cancer Patients Under Treatment of Afinitor
An observational Norwegian trial evaluating treatment with Afinitor (everolimus) in patients with metastatic renal cell carcinoma has been c…
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: Percutaneous Renal Tumor Cryoablation Followed by Biopsy [Phase 1]
A Phase 1 study evaluating percutaneous cryoablation of renal tumors with subsequent biopsy has completed, as reported by Memorial Sloan Ket…
-
CLINICAL_TRIALS research · 2016-01-05Clinical Trial Update: A SU011248 Expanded Access Protocol for Systemic Therapy of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248 [NA]
Expanded access protocol for SU011248 in patients with metastatic renal cell carcinoma who are ineligible for participation in other SU01124…
-
CLINICAL_TRIALS trial_result · 2015-12-30Clinical Trial Update: The Detection of Circulating Tumor Cells (CTCs) in Patients With Renal Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment
A completed clinical trial evaluated circulating tumor cell detection in kidney cancer patients treated with cryosurgery plus DC-CIK immunot…
-
CLINICAL_TRIALS trial_result · 2015-12-28Clinical Trial Update: Evaluating Renal Masses Using Ultrasound Intravenous Microbubble Contrast [Phase 1]
A Phase 1 trial evaluating ultrasound intravenous microbubble contrast to characterize renal masses has completed, assessing feasibility and…
-
CLINICAL_TRIALS trial_result · 2015-12-21Clinical Trial Update: Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer [Phase 2]
Phase 2 trial assessing low-intensity stem cell transplantation with multiple lymphocyte infusions for advanced kidney cancer (renal cell ca…